Mangrove Partners’s Larkspur Health Acquisition Corp. Unit LSPRU Stock Holding History

Mangrove Partners’s Portfolio LSPRU Stock Details LSPRU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,175	Closed	-$182K	–	570
2022 Q2	$182K	Sell	18,175 -181,825	-91%	-$1.82M	0.01%	467
2022 Q1	$2M	Hold	200,000	–	–	0.11%	285
2021 Q4	$2M	Buy	+200,000	New	+$2M	0.12%	291

Other funds holding LSPRU

RPO LLC Stamford, Connecticut $30.4M AUM 3.41% 1-Year Est. Return

Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

MIG

Mariner Investment Group Harrison, New York $463M AUM 13.33% 1-Year Est. Return

Mangrove Partners's LSPRU Position: Q3 2022 in Review

Mangrove Partners sold out of Larkspur Health Acquisition Corp. Unit (LSPRU) in Q3 2022, closing a stake of 18,175 shares — an estimated $182K sold.

Mangrove Partners first reported a position in LSPRU in Q4 2021 and held it in 3 quarters. The position peaked at $2M in Q4 2021. 6 funds tracked by Wall St. Rank hold LSPRU as of Q3 2022.

Mangrove Partners reported no remaining Larkspur Health Acquisition Corp. Unit position as of Q3 2022 after selling out during the quarter.
Mangrove Partners sold 18,175 Larkspur Health Acquisition Corp. Unit shares in Q3 2022, an estimated $182K.
Mangrove Partners first reported a position in Larkspur Health Acquisition Corp. Unit in Q4 2021 and held it in 3 quarters.
Mangrove Partners's Larkspur Health Acquisition Corp. Unit position peaked at $2M in Q4 2021.
6 funds tracked by Wall St. Rank held Larkspur Health Acquisition Corp. Unit as of Q3 2022.

Based on Mangrove Partners's 13F filing for Q3 2022, filed 14 Nov 2022.